Studies have associated treatment with bisphosphonates, chiefly etidronate, with improved survival in patients with GACI, an autosomal recessive disorder of spontaneous infantile arterial and periarticular calcification which is attributed to mutations in the ENPP1 gene (38). Here, ENPP1 is linked to calcification.